-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $320

Benzinga·12/22/2025 17:20:39
Listen to the news
Morgan Stanley analyst Patrick Moley maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $314 to $320.